# A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.

> **NCT06418919** · NA · ACTIVE_NOT_RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Relapsed Graves' Disease
- Thyroid; Functional Disturbance
- Radiofrequency Ablation Treatment

## Interventions

- **PROCEDURE:** Radiofrequency ablation treatment

## Key facts

- **NCT ID:** NCT06418919
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418919, "A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06418919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*